Viewing Study NCT02093403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-25 @ 3:35 AM
Study NCT ID: NCT02093403
Status: COMPLETED
Last Update Posted: 2017-12-08
First Post: 2014-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Bhavana Bhatnagar
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Secondary Acute Myeloid Leukemia View
None Untreated Adult Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AML View
None Acute Myeloid Leukemia View
None Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22) View
None adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities View
None adult Acute Myeloid Leukemia with del(5q) View
None adult Acute Myeloid Leukemia with inv(16)(p13;q22) View